| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 25.658 | 26.946 | 8.315 | 8.437 | 10.257 | 12.172 | 3.842 | 10.401 | 13.620 |
| Total Income - EUR | 0 | 25.658 | 26.946 | 8.315 | 8.437 | 10.257 | 12.172 | 3.842 | 10.401 | 13.620 |
| Total Expenses - EUR | 0 | 7.514 | 7.155 | 5.436 | 3.477 | 7.324 | 8.857 | 9.565 | 7.123 | 11.012 |
| Gross Profit/Loss - EUR | 0 | 18.144 | 19.792 | 2.880 | 4.960 | 2.933 | 3.315 | -5.723 | 3.278 | 2.608 |
| Net Profit/Loss - EUR | 0 | 17.374 | 18.977 | 2.600 | 4.717 | 2.625 | 2.950 | -5.839 | 2.711 | 2.128 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Angelis Vlad Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 61 | 60 | 59 | 58 | 57 | 55 | 56 | 55 | 55 |
| Current Assets | 45 | 18.865 | 20.758 | 12.511 | 6.632 | 3.219 | 3.677 | 1.115 | 3.825 | 7.951 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 281 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 217 | 226 | 729 | 712 | 1.235 | 957 |
| Cash | 45 | 18.865 | 20.758 | 12.511 | 6.415 | 2.994 | 2.948 | 404 | 2.310 | 6.995 |
| Shareholders Funds | 0 | 17.419 | 19.027 | 10.988 | 4.759 | 2.684 | 3.553 | -2.275 | 444 | 2.569 |
| Social Capital | 0 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 45 | 1.507 | 1.791 | 1.582 | 1.930 | 592 | 180 | 3.446 | 3.437 | 5.437 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Angelis Vlad Med Srl